As the offending agent in that treatment, fenfluramine was taken off the market, leaving phentermine still available but limited to 90 days of on-label use per the FDA
SingleAdministration SelfBoosting Microneedle patch for the treatment of obesity
This burst is a critical mediator of reperfusion injury, overwhelming the compromised antioxidant defense systems and causing widespread cellular damage
Cerebrovascular Adverse Events, Including Stroke: Increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack), including fatalities, have been reported in clinical trials of elderly patients with dementia-related psychosis treated with oral aripiprazole
described bimagrumab , a human monoclonal antibody that stimulates skeletal muscle growth by blocking the activin type II receptor (ActRII)
On the other hand, in vitro experiments demonstrated that GLP-1RA morroniside could act directly on primary microglia, and promote the mRNA levels of the M2 microglial cell markers Agr1, C206, IL-4, and IL-10